Julia P. Gregory

CIK: 0001226675

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (14.3%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NRIX

Nurix Therapeutics, Inc.

Director

BHVN

Biohaven Ltd.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

NRIX
Nurix Therapeutics, Inc.
Oct 14, 2026
Exercise(M)
Direct
22.6K shares at avg. $1.86$42K
NRIX
Nurix Therapeutics, Inc.
Oct 14, 2026
Sale(S)
Direct
22.6K shares at avg. $23.40$529K
NRIX
Nurix Therapeutics, Inc.
May 15, 2026
Award(A)
Director Stock Option (right to buy)
Direct
31.3K shares-
BHVN
Biohaven Ltd.
Apr 28, 2026
Award(A)
Stock Options (Right to buy)
Direct
68.7K shares-
NRIX
Nurix Therapeutics, Inc.
Sep 17, 2025
Exercise(M)
Direct
10.8K shares at avg. $1.86$20K
NRIX
Nurix Therapeutics, Inc.
May 19, 2025
Award(A)
Director Stock Option (right to buy)
Direct
25K shares-
BHVN
Biohaven Ltd.
May 5, 2025
Award(A)
Stock Options (Right to buy)
Direct
31.7K shares-

		Type	Shares	Price		Ownership
Oct 14, 2026	NRIX Nurix Therapeutics, Inc.	Exercise(M)	22,583	$1.86	$42,004	Direct
Oct 14, 2026	NRIX Nurix Therapeutics, Inc.	Sale(S)	22,583	$23.40	$528,528	Direct
May 15, 2026	NRIX Nurix Therapeutics, Inc.	Award(A) Director Stock Option (right to buy)	31,250	-	-	Direct
Apr 28, 2026	BHVN Biohaven Ltd.	Award(A) Stock Options (Right to buy)	68,693	-	-	Direct
Sep 17, 2025	NRIX Nurix Therapeutics, Inc.	Exercise(M)	10,750	$1.86	$19,995	Direct
May 19, 2025	NRIX Nurix Therapeutics, Inc.	Award(A) Director Stock Option (right to buy)	25,000	-	-	Direct
May 5, 2025	BHVN Biohaven Ltd.	Award(A) Stock Options (Right to buy)	31,716	-	-	Direct

1-7 of 7 transactions

About GREGORY JULIA P

GREGORY JULIA P (SEC CIK 0001226675) files insider reports with the SEC as Director of Nurix Therapeutics, Inc. (NRIX) and Director of Biohaven Ltd. (BHVN).

Signal8 holds 6 ownership filings by GREGORY JULIA P, all Form 4s, filed between May 7, 2025 and Oct 14, 2026. Those filings report 7 transactions, from May 5, 2025 to Oct 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GREGORY JULIA P's filings is in BRISBANE, CA.

Recent filings by GREGORY JULIA P

Oct 14, 2026: Option exercise of NRIX shares (Form 4, code M).
Oct 14, 2026: Open-market sale of NRIX shares (Form 4, code S).
May 15, 2026: Grant or award of NRIX derivative securities (Form 4, code A).
Apr 28, 2026: Grant or award of BHVN derivative securities (Form 4, code A).
Sep 17, 2025: Option exercise of NRIX shares (Form 4, code M).

Other insiders filing for Nurix Therapeutics, Inc. (NRIX)

van Houte Hans, Chief Financial Officer
Ring Christine, Chief Legal Officer
Hansen Gwenn, Chief Scientific Officer
Silva Paul M, Director
Saltzman Edward C, Director
Reinsdorf Judith A, Director

How to read Form 4 transaction codes